Neoleukin Therapeutics Buy Hold or Sell Recommendation

NLTXDelisted Stock  USD 13.96  0.16  1.16%   
Given the investment horizon of 90 days and your complete indifference towards market risk, our recommendation regarding Neoleukin Therapeutics is 'Not Rated'. Macroaxis provides Neoleukin Therapeutics buy-hold-or-sell recommendation only in the context of selected investment horizon and investor attitude towards risk assumed by holding NLTX positions. The advice algorithm takes into account all of Neoleukin Therapeutics' available fundamental, technical, and predictive indicators you will find on this site. Key drivers impacting Neoleukin Therapeutics' buy or sell advice are summarized below:
Real Value
12.21
Hype Value
13.96
Market Value
13.96
Naive Value
14.28
A buy or sell recommendation provided by Macroaxis is an automated directive regarding whether to purchase or sell Neoleukin Therapeutics given historical horizon and risk tolerance towards Neoleukin Therapeutics. When Macroaxis issues a 'buy' or 'sell' recommendation for Neoleukin Therapeutics, the advice is generated through an automated system that utilizes algorithms and statistical models.
  
Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in estimate.
In addition, we conduct extensive research on individual companies such as Neoleukin and provide practical buy, sell, or hold advice based on investors' investing horizon and their risk tolerance towards Neoleukin Therapeutics. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in estimate.

Execute Neoleukin Therapeutics Buy or Sell Advice

The Neoleukin recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on Neoleukin Therapeutics. Macroaxis does not own or have any residual interests in Neoleukin Therapeutics or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute Neoleukin Therapeutics' advice using the current market data and latest reported fundamentals.

Time Horizon

Risk Tolerance

Execute Advice
Sell Neoleukin TherapeuticsBuy Neoleukin Therapeutics
Not Rated
For the selected time horizon Neoleukin Therapeutics has a Risk Adjusted Performance of (0), Jensen Alpha of (0.09), Total Risk Alpha of (0.38) and Treynor Ratio of (0.12)
Our investment recommendation tool can cross-verify current analyst consensus on Neoleukin Therapeutics and to analyze the entity potential to grow in the current economic cycle. To make sure Neoleukin Therapeutics is not overpriced, please verify all Neoleukin Therapeutics fundamentals, including its short ratio, and the relationship between the cash per share and market capitalization . Given that Neoleukin Therapeutics has a price to book of 0.44 X, we recommend you to check Neoleukin Therapeutics market performance and probability of bankruptcy to ensure the company can sustain itself in the current economic cycle given your last-minute risk tolerance and investing horizon.

Neoleukin Therapeutics Trading Alerts and Improvement Suggestions

Neoleukin Therapeutics is now traded under the symbol NGNE. Please update your portfolios or report it if you believe this is an error. Report It!
Neoleukin Therapeutics is not yet fully synchronised with the market data
Neoleukin Therapeutics has a very high chance of going through financial distress in the upcoming years
Net Loss for the year was (57.56 M) with profit before overhead, payroll, taxes, and interest of 0.
Neoleukin Therapeutics currently holds about 116.46 M in cash with (45.61 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 2.73.
Roughly 16.0% of the company outstanding shares are owned by corporate insiders

Neoleukin Therapeutics Returns Distribution Density

The distribution of Neoleukin Therapeutics' historical returns is an attempt to chart the uncertainty of Neoleukin Therapeutics' future price movements. The chart of the probability distribution of Neoleukin Therapeutics daily returns describes the distribution of returns around its average expected value. We use Neoleukin Therapeutics price's Value At Risk and its Upside Potential as a relative measure of the distribution. The graph of the distribution of Neoleukin Therapeutics returns is essential to provide solid investment advice for Neoleukin Therapeutics.
Mean Return
-0.05
Value At Risk
-5.67
Potential Upside
6.67
Standard Deviation
3.40
   Return Density   
       Distribution  
Investment risk management requires an estimate of the probability of extreme price changes. Therefore, the correct representation of the distribution of Neoleukin Therapeutics historical returns presented in an easy-to-digest graphical form helps investors and money managers understand the risk-reward trade-off of different investement strategies.
Note: Acquisition by Todd Simpson of 25000 shares of Neoleukin Therapeutics subject to Rule 16b-3 [view details]

Neoleukin Therapeutics Market Momentum

Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as Neoleukin . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.

About Neoleukin Therapeutics Buy or Sell Advice

When is the right time to buy or sell Neoleukin Therapeutics? Buying financial instruments such as Neoleukin Stock isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.

Use Investing Ideas to Build Portfolios

In addition to having Neoleukin Therapeutics in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Blockchain Thematic Idea Now

Blockchain
Blockchain Theme
Companies across muliple sectors and different technology products and services that are engaged in some capacity with blockchain technolgoy or evolution of cryptocurrency. The Blockchain theme has 42 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Blockchain Theme or any other thematic opportunities.
View All  Next Launch
Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in estimate.
You can also try the Companies Directory module to evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals.

Other Consideration for investing in Neoleukin Stock

If you are still planning to invest in Neoleukin Therapeutics check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Neoleukin Therapeutics' history and understand the potential risks before investing.
Share Portfolio
Track or share privately all of your investments from the convenience of any device
AI Portfolio Architect
Use AI to generate optimal portfolios and find profitable investment opportunities
Stock Screener
Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.
Analyst Advice
Analyst recommendations and target price estimates broken down by several categories
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account
AI Investment Finder
Use AI to screen and filter profitable investment opportunities
Risk-Return Analysis
View associations between returns expected from investment and the risk you assume
Portfolio Dashboard
Portfolio dashboard that provides centralized access to all your investments